BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16255628)

  • 1. Liquid-based cytology for cervical cancer screening.
    Bentz JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE; Benoy IH; Bailleul EJ; Vandepitte J; Vereecken AJ; Bogers JJ
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer.
    Kirschner B; Simonsen K; Junge J
    Cytopathology; 2006 Aug; 17(4):187-94. PubMed ID: 16879266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SpinThin, a simple, inexpensive technique for preparation of thin-layer cervical cytology from liquid-based specimens: data on 791 cases.
    Khalbuss WE; Rudomina D; Kauff ND; Chuang L; Melamed MR
    Cancer; 2000 Jun; 90(3):135-42. PubMed ID: 10896326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
    Laiwejpithaya S; Benjapibal M; Laiwejpithaya S; Wongtiraporn W; Sangkarat S; Rattanachaiyanont M
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
    Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
    Park J; Jung EH; Kim C; Choi YH
    Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cytological methods for screening for cervical cancer].
    Kirschner B; Simonsen K; Junge J
    Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cervical screening technology.
    Stoler MH
    Mod Pathol; 2000 Mar; 13(3):275-84. PubMed ID: 10757338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
    Narimatsu R; Patterson BK
    Am J Clin Pathol; 2005 May; 123(5):716-23. PubMed ID: 15981811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
    Boon ME; Rijkaart DC; Ouwerkerk-Noordam E; Korporaal H
    Diagn Cytopathol; 2006 Sep; 34(9):644-8. PubMed ID: 16900471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the cytology laboratory: specimen processing through diagnosis.
    Joste N
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.